An online clinical model and risk stratification system to predict progression-free survival for advanced non-small-cell lung cancer patients treated with PD-(L)1 inhibitor

BACKGROUND: Our study aimed to build a risk stratification system predicting the progression-free survival (PFS) to classify patients into diverse prognostic subgroups for advanced non-small-cell lung cancer patients treated with PD-(L)1 inhibitor. METHODS: 404 patients from our center were enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Zegui, Yu, Yang, Tian, Tian, Li, Caili, Luo, Jieyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543541/
https://www.ncbi.nlm.nih.gov/pubmed/37790972
http://dx.doi.org/10.1016/j.heliyon.2023.e20465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543541/
https://www.ncbi.nlm.nih.gov/pubmed/37790972
http://dx.doi.org/10.1016/j.heliyon.2023.e20465

Ejemplares similares